Literature DB >> 29604478

AAV6 K531 serves a dual function in selective receptor and antibody ADK6 recognition.

Antonette D Bennett1, Kristine Wong1, Jordyn Lewis1, Yu-Shan Tseng1, J Kennon Smith1, Paul Chipman1, Robert McKenna1, R Jude Samulski2, Jürgen Kleinschmidt3, Mavis Agbandje-McKenna4.   

Abstract

Adeno-associated viruses (AAVs) are being developed as vectors for the treatment of genetic disorders. However, pre-existing antibodies present a significant limitation to achieving optimal efficacy for the AAV gene delivery system. Efforts aimed at engineering vectors with the ability to evade the immune response include identification of residues on the virus capsid important for these interactions and changing them. Here K531 is identified as the determinant of monoclonal antibody ADK6 recognition by AAV6, and not the closely related AAV1. The AAV6-ADK6 complex structure was determined by cryo-electron microscopy and the footprint confirmed by cell-based assays. The ADK6 footprint overlaps previously identified AAV antigenic regions and neutralizes by blocking essential cell surface glycan attachment sites. This study thus expands the available repertoire of AAV-antibody information that can guide the design of host immune escaping AAV vectors able to maintain capsid functionality.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AAV; Adeno-associated virus; Antibody; Antigenic footprint; Epitope; Neutralization; Parvoviruses; Receptor; Viral vectors

Mesh:

Substances:

Year:  2018        PMID: 29604478      PMCID: PMC6952062          DOI: 10.1016/j.virol.2018.03.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  44 in total

1.  Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies.

Authors:  N A Huttner; A Girod; L Perabo; D Edbauer; J A Kleinschmidt; H Büning; M Hallek
Journal:  Gene Ther       Date:  2003-12       Impact factor: 5.250

2.  Interpretation of electron density with stereographic roadmap projections.

Authors:  Chuan Xiao; Michael G Rossmann
Journal:  J Struct Biol       Date:  2006-10-24       Impact factor: 2.867

3.  Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.

Authors:  Brittney L Gurda; Christina Raupp; Ruth Popa-Wagner; Matthias Naumer; Norman H Olson; Robert Ng; Robert McKenna; Timothy S Baker; Jürgen A Kleinschmidt; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

4.  Structural proteins of adenovirus-associated viruses.

Authors:  J A Rose; J V Maizel; J K Inman; A J Shatkin
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

5.  Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy.

Authors:  Gregory D Hurlbut; Robin J Ziegler; Jennifer B Nietupski; Joseph W Foley; Lisa A Woodworth; Elizabeth Meyers; Scott D Bercury; Nilesh N Pande; David W Souza; Mark P Bree; Michael J Lukason; John Marshall; Seng H Cheng; Ronald K Scheule
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

6.  Characterization of adenovirus-associated virus-induced polypeptides in KB cells.

Authors:  R M Buller; J A Rose
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

7.  Limb-girdle muscular dystrophy type 2D gene therapy restores alpha-sarcoglycan and associated proteins.

Authors:  Jerry R Mendell; Louise R Rodino-Klapac; Xiomara Rosales-Quintero; Janaiah Kota; Brian D Coley; Gloria Galloway; Josepha M Craenen; Sarah Lewis; Vinod Malik; Christopher Shilling; Barry J Byrne; Thomas Conlon; Katherine J Campbell; William G Bremer; Laurence Viollet; Christopher M Walker; Zarife Sahenk; K Reed Clark
Journal:  Ann Neurol       Date:  2009-09       Impact factor: 10.422

8.  Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity.

Authors:  Michael Schmidt; Antonis Voutetakis; Sandra Afione; Changyu Zheng; Danielle Mandikian; John A Chiorini
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

9.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Authors:  Guang-Ping Gao; Mauricio R Alvira; Lili Wang; Roberto Calcedo; Julie Johnston; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

10.  Defining the stoichiometry and cargo load of viral and bacterial nanoparticles by Orbitrap mass spectrometry.

Authors:  Joost Snijder; Michiel van de Waterbeemd; Eugen Damoc; Eduard Denisov; Dmitry Grinfeld; Antonette Bennett; Mavis Agbandje-McKenna; Alexander Makarov; Albert J R Heck
Journal:  J Am Chem Soc       Date:  2014-05-07       Impact factor: 15.419

View more
  10 in total

1.  Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2.

Authors:  Antonette Bennett; Annahita Keravala; Victoria Makal; Justin Kurian; Brahim Belbellaa; Rangoli Aeran; Yu-Shan Tseng; Duncan Sousa; John Spear; Mehdi Gasmi; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2019-12-16       Impact factor: 2.867

2.  Structural Study of Aavrh.10 Receptor and Antibody Interactions.

Authors:  Mario Mietzsch; Jennifer C Yu; Jane Hsi; Paul Chipman; Felix Broecker; Zhang Fuming; Robert J Linhardt; Peter H Seeberger; Regine Heilbronn; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

Review 3.  Cryo-electron Microscopy of Adeno-associated Virus.

Authors:  Scott M Stagg; Craig Yoshioka; Omar Davulcu; Michael S Chapman
Journal:  Chem Rev       Date:  2022-05-16       Impact factor: 72.087

4.  Characterization of the Serpentine Adeno-Associated Virus (SAAV) Capsid Structure: Receptor Interactions and Antigenicity.

Authors:  Mario Mietzsch; Joshua A Hull; Victoria E Makal; Alberto Jimenez Ybargollin; Jennifer C Yu; Kedrick McKissock; Antonette Bennett; Judit Penzes; Bridget Lins-Austin; Qian Yu; Paul Chipman; Nilakshee Bhattacharya; Duncan Sousa; David Strugatsky; Peter Tijssen; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2022-05-09       Impact factor: 6.549

5.  Structurally Mapping Antigenic Epitopes of Adeno-associated Virus 9: Development of Antibody Escape Variants.

Authors:  Shanan N Emmanuel; J Kennon Smith; Jane Hsi; Yu-Shan Tseng; Matias Kaplan; Mario Mietzsch; Paul Chipman; Aravind Asokan; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2021-11-10       Impact factor: 6.549

6.  High-Resolution Structural Characterization of a New Adeno-associated Virus Serotype 5 Antibody Epitope toward Engineering Antibody-Resistant Recombinant Gene Delivery Vectors.

Authors:  Ariana Jose; Mario Mietzsch; J Kennon Smith; Justin Kurian; Paul Chipman; Robert McKenna; John Chiorini; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

Review 7.  Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family.

Authors:  Shanan N Emmanuel; Mario Mietzsch; Yu Shan Tseng; James Kennon Smith; Mavis Agbandje-McKenna
Journal:  Viral Immunol       Date:  2020-04-21       Impact factor: 2.257

Review 8.  Biophysical, Biochemical, and Cell Based Approaches Used to Decipher the Role of Carbonic Anhydrases in Cancer and to Evaluate the Potency of Targeted Inhibitors.

Authors:  Mam Y Mboge; Anusha Kota; Robert McKenna; Susan C Frost
Journal:  Int J Med Chem       Date:  2018-07-16

9.  Adeno-associated virus-binding antibodies detected in cats living in the Northeastern United States lack neutralizing activity.

Authors:  Kei Adachi; Gregory A Dissen; Alejandro Lomniczi; Qing Xie; Sergio R Ojeda; Hiroyuki Nakai
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

10.  Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features.

Authors:  Mario Mietzsch; Ariana Jose; Paul Chipman; Nilakshee Bhattacharya; Nadia Daneshparvar; Robert McKenna; Mavis Agbandje-McKenna
Journal:  Viruses       Date:  2021-01-13       Impact factor: 5.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.